Shandong Sito Bio-technology Co., Ltd.

¥11.20As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300583Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (12.07%)
Div yield 0.13%
ROE 1.65%
Biotechnology
Beta (5Y) 0.27
PE TTM 72.74
TSR TTM (26.67%)
Mkt cap ¥2.125B
ROIC 1.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
10.92%
(78.65%)
Sell 3|4|9|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.16
0.15
31.05%
23.91%
9.67%
0.01%
Revenue¥M
203.3
204.4
208.4
207.3
(1.47%)
(0.75%)
2.45%
1.86%
Peers (US$318.5M)
Cap (US$)
PE
316.1M
—
314.7M
—
301.1M
76.93x
Capital
TTM
5Y
10Y
Leveragex
5.205
0.188
0.167
EBIT/Intx
1.439
0.642
0.575
Own earn%
(1.19)
(186.66)
(163.97)
Sh yield%
33.38
33.00
32.92
Owners
Insiders/Inst%
3.51
49.91
Short interest%
2.68
SBC / revenue%
1.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
3